Subgen AI AB Stock Nasdaq Stockholm

SUBGEN

SE0014401121

Delayed Nasdaq Stockholm 19:11:56 07/09/2026 +04			5-day change	1st Jan Change
0.0380 ^SEK	+1.60%		+3.26%	-96.07%

08-20	Subgen AI AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Calendar Thursday, August 20	FW

Magnasense AB, formerly AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and neurology space. The Company offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. It aims to provide personalized treatment by tracking drugs levels in individuals. Magnasense AB combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.

Employees

Sector

More about the company

Quotes

Date	Price	Change	Volume
07/09/26	SEK 0.0380	+1.60%	14,564,982
04/09/26	SEK 0.0374	-4.59%	13,098,499
03/09/26	SEK 0.0392	+0.51%	26,004,309
02/09/26	SEK 0.0390	-7.14%	41,405,279
01/09/26	SEK 0.0420	+14.13%	55,008,622

Delayed Quote Nasdaq Stockholm

More quotes

Market Cap	74.11M 7.75M 6.67M 6.27M 5.73M 10.72M 731M 10.75M 28.76M 375M 29.09M 28.45M 1.21B	P/E 2024 *	-	P/E 2025	-2.38x
Enterprise Value	159M 16.67M 14.34M 13.49M 12.33M 23.06M 1.57B 23.12M 61.88M 807M 62.59M 61.22M 2.6B	EV / Sales 2024 *	-	EV / Sales 2025	5.24x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

08-20	Subgen AI AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Calendar Thursday, August 20	FW
08-11	Sweden's Subgen AI Names New CFO	MT
08-11	Subgen AI Group Announces Chief Financial Officer Changes, Effective August 17, 2026	CI
06-25	Subgen AI Files Appeal Against SEK12 Million Administrative Fine	MT
06-24	Subgen AI appeals €1.1m penalty	FW
06-24	Subgen AI AB Files Appeal Against Administrative Fine	CI
06-24	Nasdaq First North 25 reshuffles, here are the changes	FW
06-12	Subgen AI increases stake in Substrate AI as planned via directed non-cash issue	FW
06-05	Subgen AI increases stake in Substrate AI via 59.5 million SEK non-cash issue	FW
06-04	Swedish Court Upholds SEK12 Million Fine on Subgen AI Over Market Abuse Violations	MT
06-04	Administrative Court upholds administrative fine against Subgen AI	FW
06-04	The Administrative Court Upheld the Administrative Fine Imposed by the Swedish Financial Supervisory Authority Against Magnasense and Subgen AI Will Evaluate an Appeal	CI

09-02	Subgen AI announces that subsidiary Substrate AI has received second contribution of approximately EUR 3.9 million from investors	AQ
09-01	Subgen AI has resolved on two directed shares issues of a total of approximately SEK 12.7 million	AQ
08-20	Subgen AI Interim Report Q2 April-June 2026	AQ
08-11	Subgen AI Group Appoints Fredrik Lundqvist as Chief Financial Officer	AQ
07-29	Subgen AI announces that subsidiary Substrate AI has received initial contribution of approximately EUR 3.9 million from investors	AQ

1 week	+3.31%
Current month	+1.63%
1 month	-23.05%
3 months	-57.79%
6 months	-86.92%
Current year	-96.13%

1 week	0.04	0.04
1 month	0.04	0.06
3 years	0.03	1,657
5 years	0.03	358,000

Subgen AI AB Stock Nasdaq Stockholm

Stocks

SUBGEN

SE0014401121

Valuation : Subgen AI AB

Chart: Subgen AI AB

Latest news : Subgen AI AB

Press Releases : Subgen AI AB

Quotes and Performance

Price Extremes

Managers and Directors : Subgen AI AB

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Lorenzo Serratosa Gallardo CEO	Chief Executive Officer	57	28/11/2025
Marta Gomez ADM	Chief Administrative Officer	-	28/11/2025
Bren Worth CTO	Chief Tech/Sci/R&D Officer	-	28/11/2025

Director	Title	Age	Since
Fredrik Häglund BRD	Director/Board Member	51	01/05/2020
William Vickery BRD	Director/Board Member	59	01/06/2022
Michael Schwartz BRD	Director/Board Member	56	01/01/2024

	2024	2025
Net sales	17.82M 1.86M 1.6M 1.51M 1.38M 2.58M 176M 2.58M 6.92M 90.24M 7M 6.84M 291M	204M 21.36M 18.38M 17.3M 15.8M 29.56M 2.02B 29.64M 79.31M 1.03B 80.22M 78.47M 3.33B
Net income	2.3M 240K 206K 194K 177K 332K 22.66M 333K 891K 11.62M 901K 881K 37.45M	-50.92M -5.32M -4.58M -4.31M -3.94M -7.36M -503M -7.38M -19.76M -258M -19.99M -19.55M -831M
Net Debt	10.61M 1.11M 955K 898K 821K 1.53M 105M 1.54M 4.12M 53.74M 4.17M 4.08M 173M	85.35M 8.92M 7.68M 7.22M 6.6M 12.34M 842M 12.38M 33.12M 432M 33.5M 32.77M 1.39B